An innovative software solution for personalized pharmacotherapy.

Area of Science:

• Pharmacogenomics
• Clinical Pharmacology
• Health Informatics

Background:

• Adverse drug reactions (ADRs) represent a major healthcare burden, causing significant mortality, morbidity, and economic costs globally.
• Drug metabolism, influenced by genetic variations (polymorphisms) in cytochrome P450 enzymes, dictates individual responses to medications, affecting efficacy and toxicity.
• The complexity of polypharmacy, drug-drug interactions, and environmental factors further complicates predicting drug responses and necessitates advanced decision support.

Purpose of the Study:

• To highlight the prevalence and impact of drug-drug and drug-gene interactions in clinical practice.
• To introduce a pharmaceutical decision support software solution designed to provide individualized treatment recommendations.
• To address the need for intuitive and informative tools to manage complex medication regimens.

Main Methods:

• Review of existing literature on adverse drug reactions and drug metabolism.
• Development of proprietary algorithms to analyze drug-gene and drug-drug interactions.
• Integration of patient-specific data to generate dosage modification recommendations.

Main Results:

• Drug-gene and drug-drug interactions contribute to significant adverse events, hospital admissions, and healthcare costs.
• Cytochrome P450 polymorphisms can lead to poor or enhanced drug metabolism, impacting therapeutic outcomes.
• The Rx Factor software provides clinicians with actionable dosage recommendations for individual patients.

Conclusions:

• Personalized medicine approaches are crucial for optimizing drug therapy and minimizing adverse events.
• Decision support software utilizing proprietary algorithms can effectively guide clinicians in managing complex drug interactions.
• Implementing tools like The Rx Factor can improve patient safety, treatment efficacy, and compliance.